The DOI matches its Crossref record; 475 of the 475 references it cites were found in a registry or an index.
Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
Open accessAbstract
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory A(1) receptors (A1R) and facilitatory A(2A) receptors (A2AR), mostly controlling excitatory glutamatergic synapses: A1R impose a tonic brake on excitatory transmission, whereas A2AR are selectively engaged to promote synaptic plasticity phenomena. This neuromodulatory role of adenosine is strikingly similar to the role of adenosine in the control of brain disorders; thus, A1R mostly act as a hurdle that needs to be overcame to begin neurodegeneration and, accordingly, A1R only effectively control neurodegeneration if activated in the temporal vicinity of brain insults; in contrast, the blockade of A2AR alleviates the long-term burden of brain disorders in different neurodegenerative conditions such as ischemia, epilepsy, Parkinson's or Alzheimer's disease and also seem to afford benefits in some psychiatric conditions. In spite of this qualitative agreement between neuromodulation and neuroprotection by A1R and A2AR, it is still unclear if the role of A1R and A2AR in the control of neuroprotection is mostly due to the control of glutamatergic transmission, or if it is instead due to the different homeostatic roles of these receptors related with the control of metabolism, of neuron-glia communication, of neuroinflammation, of neurogenesis or of the control of action of growth factors. In spite of this current mechanistic uncertainty, it seems evident that targeting adenosine receptors might indeed constitute a novel strategy to control the demise of different neurological and psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,962
Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus
van Praag, H., Kempermann, G., & Gage, F. H. (1999) · Nature Neuroscience · doi:10.1038/6368 · Cited by 3,880
Paxinos, G. (1985) · Cited by 3,715
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats
Altman, J., & Das, G. D. (1965) · Journal of Comparative Neurology · doi:10.1002/cne.901240303 · Cited by 3,592
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 4×
“receptors should be the main targets of caffeine [4,8], there is evidence that caffeine can affect different other molecular targets”
BackgroundInfluentialInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Epilepsy: A Comprehensive Textbook
(2008) · JAMA · doi:10.1001/jama.300.4.443-a · Cited by 2,357
Long-Distance Neuronal Migration in the Adult Mammalian Brain
Lois, C., & Álvarez-Buylla, A. (1994) · Science · doi:10.1126/science.8178174 · Cited by 2,331
Evidence-based health policy—lessons from the Global Burden of Disease Study
Murray, C. J. L., & Lopez, A. D. (1996) · Science · doi:10.1126/science.274.5288.740 · Cited by 2,178
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,028
Neurogenesis in the adult is involved in the formation of trace memories
Shors, T. J., Miesegaes, G. R., Beylin, A. V., Zhao, M., Rydel, T. A., & Gould, E. (2001) · Nature · doi:10.1038/35066584 · Cited by 2,014
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Manic-Depressive Insanity and Paranoia.
(1921) · JAMA · doi:10.1001/jama.1921.02630330070026 · Cited by 1,612
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,503
Drury, A. N., & Szent‐Györgyi, A. (1929) · The Journal of Physiology · doi:10.1113/jphysiol.1929.sp002608 · Cited by 1,493
Altman, J. (1969) · The Journal of Comparative Neurology · doi:10.1002/cne.901370404 · Cited by 1,489
Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463
Carlezon, W. A., Duman, R. S., & Nestler, E. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,382
Manic Depressive Insanity and Paranoia
Kraepelin, E. (1921) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-192104000-00057 · Cited by 1,319
Kalaria, R. N., Maestre, G. E., Arizaga, R., Friedland, R. P., Galasko, D., Hall, K., Luchsinger, J. A., Ogunniyi, A., Perry, E. K., Potocnik, F., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70169-8 · Cited by 1,233
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
Rat forebrain neurogenesis and striatal neuron replacement after focal stroke
Parent, J. M., Vexler, Z. S., Gong, C., Derugin, N., & Ferriero, D. M. (2002) · Annals of Neurology · doi:10.1002/ana.10393 · Cited by 1,020
A unified hypothesis on the lineage of neural stem cells
Álvarez-Buylla, A., García‐Verdugo, J. M., & Tramontin, A. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067582 · Cited by 1,018
ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTRand Sortilin
Teng, H. K., Teng, K. K., Lee, R., Wright, S., Tevar, S., Almeida, R. D., Kermani, P., Torkin, R., Chen, Z.-Y., Lee, F. S., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5123-04.2005 · Cited by 1,013
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., & Gage, F. H. (2002) · Development · doi:10.1242/dev.00203 · Cited by 1,003
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 978
Adult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Sattin, A., & Rall, T. W. (1970) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15197-3 · Cited by 893
The role of adenosine in the regulation of coronary blood flow.
Berne, R. M. (1980) · Circulation Research · doi:10.1161/01.res.47.6.807 · Cited by 884
Purinergic signalling in neuron–glia interactions
Fields, R. D., & Burnstock, G. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1928 · Cited by 878
VEGF links hippocampal activity with neurogenesis, learning and memory
Cao, L., Jiao, X., Zuzga, D. S., Liu, Y., Fong, D. M., Young, D., & During, M. J. (2004) · Nature Genetics · doi:10.1038/ng1395 · Cited by 850
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression
Woo, N. H., Teng, H. K., Siao, C.-J., Chiaruttini, C., Pang, P. T., Milner, T. A., Hempstead, B. L., & Lu, B. (2005) · Nature Neuroscience · doi:10.1038/nn1510 · Cited by 815
Brain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801
Neurogenesis in the Adult Brain
Gage, F. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00612.2002 · Cited by 796
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
Latini, S., & Pedata, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00607.x · Cited by 779
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745 · cited 1×
“To balance early changes in inhibitory dopaminergic tonus, compensatory mechanisms, such as plastic adaptations in the cortico-striatal pathway [208–210], probably delaymotor impairment and justify the existence of a pre-symptomatic period [211] preceding the gradual appearance of symptoms.”
BackgroundFredholm, B. B., Chen, J., Cunha, R. A., Svenningsson, P., & Vaugeois, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 721
Self-citationSitkovsky, M. V., Lukashev, D. E., Apasov, S. G., Kojima, H., Koshiba, M., Caldwell, C. C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 697
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90173-9 · Cited by 649
Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons
Song, H., Stevens, C. F., & Gage, F. H. (2002) · Nature Neuroscience · doi:10.1038/nn844 · Cited by 641
Kronenberg, G., Reuter, K., Steiner, B., Brandt, M. D., Jessberger, S., Yamaguchi, M., & Kempermann, G. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10945 · Cited by 640 · cited 1×
“gyrus of the hippocampus [422,442–444].”
Cunha, R. A. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00034-6 · Cited by 632
Self-citationChen, J., Xu, K., Petzer, J. P., Staal, R. G. W., Xu, Y., Beilstein, M. A., Sonsalla, P. K., Castagnoli, K., Castagnoli, N. J., & Schwarzschild, M. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0001.2001 · Cited by 617
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 610
Neurogenesis in the Adult Brain: New Strategies for Central Nervous System Diseases
Lie, D. C., Song, H., Colamarino, S. A., Ming, G., & Gage, F. H. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121631 · Cited by 601
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 600
Olson, A. K., Eadie, B. D., Ernst, C., & Christie, B. R. (2006) · Hippocampus · doi:10.1002/hipo.20157 · Cited by 592
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 591
Self-citationRole of brain-derived neurotrophic factor in Huntington's disease
Zuccato, C., & Cattaneo, E. F. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 568
A2AAdenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice
Chen, J., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D. G., Moskowitz, M. A., Fink, J. S., & Schwarzschild, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09192.1999 · Cited by 557
Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Cunha, R. A. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-0649-1 · Cited by 555
Self-citationHeurteaux, C., Lauritzen, I., Widmann, C., & Lazdunski, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4666 · Cited by 553
Ferré, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxé, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 551
Adult neurogenesis and neural stem cells of the central nervous system in mammals
Taupin, P., & Gage, F. H. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10378 · Cited by 538
Functional impairment in social phobia.
Schneier, F. R., Heckelman, L., Garfinkel, R. S., Campeas, R. B., Fallon, B. A., Gitow, A., Street, L. L., Bene, D. D., & Liebowitz, M. R. (1994) · PubMed · Cited by 534
Adenosine receptors in the nervous system: pathophysiological implications
Ribeiro, J. A., Sebastião, A. M., & de Mendonça, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00155-7 · Cited by 521
Distribution, biochemistry and function of striatal adenosine A2A receptors
Svenningsson, P. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00011-8 · Cited by 516
Johansson, B. A., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez‐Llort, L., Escorihuela, R. M., Fernández‐Teruel, A., Wiesenfeld‐Hallin, Z., Xu, X.-J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161292398 · Cited by 506
Hillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R. P., Terasmaa, A., Hansson, A. C., Watson, S. J., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 499
Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 494
Neurogenesis in adult primate neocortex: an evaluation of the evidence
RAKIC, P. T. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn700 · Cited by 494
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin, J., Fang, Z.-H., Yu, Z.-X., Wang, C.-E., Li, S., & Li, X. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508072 · Cited by 488
Activation of Trk neurotrophin receptors in the absence of neurotrophins
Lee, F. S., & Chao, M. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061020198 · Cited by 484
Adenosine: A potential mediator of seizure arrest and postictal refractoriness
During, M. J., & Spencer, D. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320504 · Cited by 478
Arendash, G. W., Schleif, W. S., Rezai-Zadeh, K. P., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D. C., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 476
Thompson, S. M., Haas, H. L., & Gähwiler, B. H. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019168 · Cited by 476
Quality of Life in Panic Disorder
Markowitz, J. S. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110026004 · Cited by 471
Molecular targets for antiepileptic drug development
Meldrum, B., & Rogawski, M. (2011) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.010 · Cited by 454
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP Sw,Ind ) mice
Jin, K., Galván, V., Xie, L., Mao, X. O., Gorostiza, O. F., Bredesen, D. E., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403678101 · Cited by 444
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization
Canals, M., Marcellino, D. J., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K. A., Fuxé, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 444
An Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440
Adenosine and the concept of ‘retaliatory metabolites’
Newby, A. C. (1984) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(84)90176-2 · Cited by 430
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428
BIOCHEMISTRY, LOCALIZATION AND FUNCTIONAL ROLES OF ECTO-NUCLEOTIDASES IN THE NERVOUS SYSTEM
Zimmermann, H. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00026-3 · Cited by 426
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & Raymond, L. A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 410
Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system
Rosin, D. L., Robeva, A., Woodard, R. L., Guyenet, P. G., & Linden, J. M. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981116)401:2 · Cited by 394
Adenosine A2A receptors and basal ganglia physiology
Schiffmann, S. N., Fisone, G., Moresco, R. M., Cunha, R. A., & Ferré, S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.05.001 · Cited by 393
Self-citationAxon pathology in neurological disease: a neglected therapeutic target
Coleman, M. P., & Perry, V. H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02255-5 · Cited by 387
GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
Kearns, C. M., & Gash, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01366-p · Cited by 379
Rebola, N., Lujan, R., Cunha, R. A., & Mulle, C. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.023 · Cited by 376
Self-citationTanapat, P., Hastings, N. B., Rydel, T. A., Galea, L. A. M., & Gould, E. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1297 · Cited by 376
Dall'Igna, O. P. P., Neto, P. F., Gomes, M. W. S., Souza, D. O., Cunha, R. A., & Lara, D. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372
Self-citationScanziani, M., Capogna, M., Gähwiler, B. H., & Thompson, S. M. (1992) · Neuron · doi:10.1016/0896-6273(92)90244-8 · Cited by 370
The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat
Ginsborg, B. L., & Hirst, G. D. S. (1972) · The Journal of Physiology · doi:10.1113/jphysiol.1972.sp009916 · Cited by 369
Ferré, S., Karcz‐Kubicha, M., Hope, B. T., Popoli, P., Burgueño, J., Gutiérrez, M. A., Casadó, V., Fuxé, K., Goldberg, S. R., Lluı́s, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393799 · Cited by 365
GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
Arenas, E., Trupp, M., Åkerud, P., & Ibáñez, C. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90024-1 · Cited by 363
Does caffeine intake protect from Alzheimer's disease?
Maia, L., & de Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 361
Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
Keshavan, M. S., TANDON, R., Boutros, N. N., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.020 · Cited by 360
Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 358
Self-citationWu, L.-G., & Saggau, P. (1994) · Neuron · doi:10.1016/0896-6273(94)90321-2 · Cited by 348
Nisenbaum, E., & Wilson, C. J. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04449.1995 · Cited by 348
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347
Caffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens
Solinas, M., Ferré, S., You, Z.-B., Karcz-Kubicha, M., Popoli, P., & Goldberg, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06321.2002 · Cited by 338
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
Gouras, G. K., Almeida, C. G., & Takahashi, R. H. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.022 · Cited by 338
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety
Alsene, K., Deckert, J., Sand, P., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300232 · Cited by 334
Lindström, L., Gefvert, O., Hagberg, G., Lundberg, T., Bergström, M., Hartvig, P., & Långström, B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00109-2 · Cited by 332
Adenosine A 2A receptor antagonist treatment of Parkinson’s disease
Bara‐Jimenez, W., Sherzai, A. Z., Dimitrova, T. D., Favit, A., Bibbiani, F., Gillespie, M., Morris, M. J., Mouradian, M. M., & Chase, T. N. (2003) · Neurology · doi:10.1212/01.wnl.0000073136.00548.d4 · Cited by 328
Tsutsui, S., Schnermann, J. B., Noorbakhsh, F., Henry, S. D., Yong, V. W., Winston, B. W., Warren, K. G., & Power, C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4271-03.2004 · Cited by 324
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 322
Adenosine signaling and function in glial cells
Boison, D., Chen, J., & Fredholm, B. B. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.131 · Cited by 319
The corticostriatal pathway in Huntington's disease
Cepeda, C., Wu, N.-P., André, V. M., Cummings, D. M., & LEVINE, M. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.001 · Cited by 318
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Coleman, P., Federoff, H., & Kurlan, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140626.48118.0a · Cited by 314
Post, R. M. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.003 · Cited by 312
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Rudolphi, K. A., & Schubert, P. (1995) · Springer eBooks · doi:10.1007/978-1-4615-2011-5_43 · Cited by 296
Localized striatal delivery of GDNF as a treatment for Parkinson disease
Kirik, D., Georgievska, B., & Björklund, A. (2004) · Nature Neuroscience · doi:10.1038/nn1175 · Cited by 289
Nemeroff, C. B., & Owens, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn943 · Cited by 284
Boyd, J. G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00183-3 · Cited by 281
Lei, W., Jiao, Y., Mar, N. D., & Reiner, A. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1990-04.2004 · Cited by 277
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors
Higley, M. J., & Sabatini, B. L. (2010) · Nature Neuroscience · doi:10.1038/nn.2592 · Cited by 271
Adenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., Lubitz, D. K. J. E. V., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 265
Wylen, D. G. L. V., Park, T. S., Rubio, R., & Berne, R. M. (1986) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1986.97 · Cited by 261
Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients with Schizophrenia
Potter, D., Summerfelt, A. T., Gold, J. M., & Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj050 · Cited by 258
Neuroprotection by caffeine and adenosine A 2A receptor blockade of β ‐amyloid neurotoxicity
Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 255
Self-citationFerré, S., Quiroz, C., Woods, A. S., Cunha, R. A., Popoli, P., Ciruela, F., Lluı́s, C., Franco, R., Azdad, K., & Schiffmann, S. N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480108 · Cited by 254
Self-citationAdenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons
Schiffmann, S., & Vanderhaeghen, J. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01080.1993 · Cited by 253
Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. A., & de Wit, H. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.17 · Cited by 252
Prediger, R. D., Batista, L. C., & Takahashi, R. N. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.012 · Cited by 251
Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice
Li, T., Ren, G., Lusardi, T. A., Wilz, A., Lan, J. Q., Iwasato, T., Itohara, S., Simon, R. P., & Boison, D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33737 · Cited by 251
Antiparkinsonian effect of a new selective adenosine A2Areceptor antagonist in MPTP-treated monkeys
Grondin, R., Bédard, P. J., Tahar, A. H., Grégoire, L., Mori, A., & Kase, H. (1999) · Neurology · doi:10.1212/wnl.52.8.1673 · Cited by 250
Adenosine: does it have a neuroprotective role after all?
de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00033-3 · Cited by 248
Kanda, T., Jackson, M. J., Smith, L. A., Pearce, R. K. B., Nakamura, J., Kase, H., Kuwana, Y., & Jenner, P. G. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7350 · Cited by 248
Adenosine-dopamine interactions in the ventral striatum
Ferré, S. (1997) · Psychopharmacology · doi:10.1007/s002130050380 · Cited by 247
Caffeine, Mental Health, and Psychiatric Disorders
Lara, D. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1378 · Cited by 245
Adenosine kinase, epilepsy and stroke: mechanisms and therapies
Boison, D. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.008 · Cited by 243
Cui, Q., Yip, H. K.-F., Zhao, R. C., So, K., & Harvey, A. R. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(02)00037-4 · Cited by 243
Chen, J., Sonsalla, P. K., Pedata, F., Melani, A., Domenici, M. R., Popoli, P., Geiger, J. D., Lopes, L. V., & de Mendonça, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.09.002 · Cited by 242
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1408 · Cited by 241
Self-citationThe electrophysiology of adenosine in the mammalian central nervous system
Greene, R. W., & Haas, H. L. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90005-l · Cited by 233
The adenosine kinase hypothesis of epileptogenesis
Boison, D. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.002 · Cited by 224
Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease
Ikeda, K., Kurokawa, M., Aoyama, S., & Kuwana, Y. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00694.x · Cited by 224
Chapter 11 Adenosine and Neuroprotection
Fredholm, B. B. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60723-0 · Cited by 218
Popoli, P., Pintor, A., Domenici, M. R., Frank, C., Tebano, M. T., Pèzzola, A., Scarchilli, L., Quarta, D., Reggio, R., Malchiodi‐Albedi, F., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01967.2002 · Cited by 218
Shiozaki, S., Ichikawa, S., Nakamura, J., Kitamura, S., Yamada, K., & Kuwana, Y. (1999) · Psychopharmacology · doi:10.1007/s002130051146 · Cited by 216
Magavi, S. S. P., Mitchell, B. D., Szentirmai, O., Carter, B. S., & Macklis, J. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2250-05.2005 · Cited by 215
Mishra, S. K., Braun, N., Shukla, V., Füllgrabe, M., Schomerus, C., Korf, H., Gachet, C., Ikehara, Y., Sévigny, J., Robson, S. C., et al. (2006) · Development · doi:10.1242/dev.02233 · Cited by 215
Silinsky, E. M. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015019 · Cited by 214
Symptoms and duration of the prodromal phase in parkinson's disease
Gonera, E. G., Hof, M. V., Berger, H. J. C., van Weel, C., & Horstink, M. W. I. M. (1997) · Movement Disorders · doi:10.1002/mds.870120607 · Cited by 212
Jin, K., LaFevre-Bernt, M. A., Sun, Y., Chen, S., Gafni, J., Crippen, D., Logvinova, A. V., Ross, C. A., Greenberg, D. A., & Ellerby, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506375102 · Cited by 212
Sleep deprivation suppresses neurogenesis in the adult hippocampus of rats
Guzmán-Marı́n, R., Suntsova, N., Methippara, M. M., Greiffenstein, R., Szymusiak, R. S., & McGinty, D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04376.x · Cited by 210
Gouder, N., Fritschy, J., & Boison, D. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.03603.x · Cited by 208
Sawai, H., Clarke, D. B., Kittlerová, P., Bray, G. M., & Aguayo, A. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03887.1996 · Cited by 208
Li, H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1227 · Cited by 207
Kirik, D., Rosenblad, C., & Björklund, A. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00274.x · Cited by 206
Strain, E. C. (1994) · JAMA · doi:10.1001/jama.272.13.1043 · Cited by 204
Facilitated Glutamatergic Transmission in the Striatum of D2Dopamine Receptor-Deficient Mice
Cepeda, C., Hurst, R. S., Altemus, K. L., Flores‐Hernández, J., Calvert, C. R., Jokel, E. S., Grandy, D. K., Low, M. J., Rubinstein, M., Ariano, M. A., et al. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.659 · Cited by 203
Rebola, N., Canas, P. M., Oliveira, C. R., & Cunha, R. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.014 · Cited by 202
Self-citationScholz, K. P., & Miller, R. J. (1992) · Neuron · doi:10.1016/0896-6273(92)90134-y · Cited by 201
Monopoli, A., Lozza, G., Forlani, A., Mattavelli, A., & Ongini, E. (1998) · Neuroreport · doi:10.1097/00001756-199812010-00034 · Cited by 200
Yacoubi, M. E., Ledent, C. A., Parmentier, M., Bertorelli, R., Ongini, E., Costentin, J., & Vaugeois, J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704240 · Cited by 199
Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice
Cao, C., Cirrito, J. R., Lin, X., Wang, L., Verges, D. K., Dickson, A., Mamcarz, M. B., Zhang, C., Mori, T., Arendash, G. W., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1071 · Cited by 198
Mitchell, J., Lupica, C. R., & Dunwiddie, T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03439.1993 · Cited by 197
Rodrigues, R. J., Alfaro, T. M., Rebola, N., Oliveira, C. R., & Cunha, R. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02887.x · Cited by 196
Self-citationPotential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Cunha, R. A., Ferré, S., Vaugeois, J., & Chen, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480090 · Cited by 195
Self-citationJin, Y. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7980 · Cited by 195
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
Lim, D., Fedrizzi, L., Tartari, M., Zuccato, C., Cattaneo, E. F., Brini, M., & Carafoli, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704704200 · Cited by 194
Fedele, D., Gouder, N., Güttinger, M., Gabernet, L., Scheurer, L., Rülicke, T., Crestani, F., & Boison, D. (2005) · Brain · doi:10.1093/brain/awh555 · Cited by 193
Ciruela, F., Burgueño, J., Casadó, V., Canals, M., Marcellino, D. J., Goldberg, S. R., Bäder, M., Fuxé, K., Agnati, L. F., Lluís, C., et al. (2004) · Analytical Chemistry · doi:10.1021/ac049295f · Cited by 192
Dunwiddie, T. V., & Haas, H. L. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015907 · Cited by 192
Lopes, L. V., Cunha, R. A., & Ribeiro, J. A. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.3196 · Cited by 191
Self-citationCaffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
Chen, X., Lan, X., Roche, I., Liu, R., & Geiger, J. D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05697.x · Cited by 189
Anxiety and depression associated with caffeinism among psychiatric inpatients
Greden, J. F., Fontaine, P., Lubetsky, M. J., & Chamberlin, K. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.8.963 · Cited by 189
Kochanek, P. M., Vagni, V., Janesko, K. L., Washington, C. B., Crumrine, P. K., Garman, R. H., Jenkins, L. W., Clark, R. S. B., Homanics, G. E., Dixon, C. E., et al. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600218 · Cited by 188
Purinergic mechanisms in epilepsy
Dragunow, M. (1988) · Progress in Neurobiology · doi:10.1016/0301-0082(88)90028-7 · Cited by 187
RESEARCH ARTICLE: Up‐regulation of Adenosine Receptors in the Frontal Cortex in Alzheimer's Disease
Albasanz, J. L., Perez, S., Barrachina, M., Ferrer, I., & Martı́n, M. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00112.x · Cited by 182
Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus
Yoon, K. W., & Rothman, S. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-05-01375.1991 · Cited by 182
Diógenes, M. J., Fernandes, C. D. C., Sebastião, A. M., & Ribeiro, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4454-03.2004 · Cited by 180
Angulo-Pueyo, E., Casadó, V., Mallol, J., Canela, E. I., Viñals, F., Ferrer, I., Lluís, C., & Franco, R. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00475.x · Cited by 179
Cui, Q., Lü, Q., So, K., & Yip, H. K.-F. (1999) · PubMed · Cited by 177
Ruitenberg, M. J., Plant, G. W., Hamers, F. P. T., Wortel, J., Blits, B., Dijkhuizen, P. A., Gispen, W. H., Boer, G. J., & Verhaagen, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07045.2003 · Cited by 177
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
Takahashi, R. N. (2007) · Frontiers in bioscience · doi:10.2741/2870 · Cited by 176
Adenosinergic cardioprotection: Multiple receptors, multiple pathways
Peart, J. N., & Headrick, J. P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.004 · Cited by 175
Nucleotide signaling in nervous system development
Zimmermann, H. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0067-4 · Cited by 174
Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease
Pisani, A., Centonze, D., Bernardi, G., & Calabresi, P. (2005) · Movement Disorders · doi:10.1002/mds.20394 · Cited by 171
Fuxé, K., & Ungerstedt, U. (1974) · PubMed · Cited by 171
Yu, L., Shen, H., Coelho, J. E., Araújo, I. M., Huang, Q., Day, Y., Rebola, N., Canas, P. M., Rapp, E. K., Ferrara, J., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21313 · Cited by 170
Self-citationAdenosine A1 receptors are crucial in keeping an epileptic focus localized
Fedele, D., Li, T., Lan, J. Q., Fredholm, B. B., & Boison, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.133 · Cited by 170
Lundblad, M., Vaudano, E., & Cenci, M. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01632.x · Cited by 169
Anoxic preconditioning in hippocampal slices: role of adenosine
Pérez‐Pinzón, M. A., Mumford, P. L., Rosenthal, M., & Sick, T. J. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00311-9 · Cited by 168
Flagged first, then by citations
Research works printed but not linked: 3
- Porciúncula, 2006, Blockade of adenosine A 2A receptors differently alters convulsive behaviour and prevents hippocampal damage in two models of temporal lobe epilepsy, Purinergic Signal, 2, 134
- Fernandez, 2008, .U.-C.I. Group, The safety and efficacy of istradephylline, an adenosine A2A antagonist, as monotherapy in Parkinson's disease: results of the KW-6002-US-051 trial, Mov. Disord., 23, S87
- Kaster, 2010, Genetic or pharmacological blockade of adenosine A2A receptors prevents behavioral and morphological effects of chronic stress in mice, Purinergic Signal, 6, S93
Cited by
Sorted by citations
Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Adenosine receptors as drug targets — what are the challenges?
Chen, J., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 921
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Molecular Targets of Cannabidiol in Neurological Disorders
Bih, C. I., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M. L., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 602
The Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557
Metadata
- Authors
- Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A.
- Affiliations
- University of Coimbra (PT)
- Corresponding author
- Cunha, Rodrigo A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 1808
- Issue
- 5
- Pages
- 1380-1399
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2081196843
- Cited by
- 419
- References
- 473
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 15 · 2023: 21 · 2022: 30 · 2021: 24 · 2020: 37 · 2019: 43 · 2018: 36 · 2017: 30 · 2016: 27 · 2015: 38 · 2014: 32 · 2013: 22 · 2012: 26
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- adenosine receptors, adenosine A1 receptor, adenosine A2A receptor, neuroprotection, neurodegeneration, neuromodulation, glutamatergic synapses, synaptic plasticity, ischemia, epilepsy, Parkinson's disease, Alzheimer's disease, neuroinflammation, neuron-glia communication, neurogenesis, growth factors, mental illness, adenosine receptor agonists
- MeSH terms
- Animals, Brain Diseases, Humans, Nerve Degeneration, Receptors, Purinergic P1, Neurotransmitter Agents, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review